Similarly, CRISPR-Cas9-mediated deletion of individual components of the TP63 SEs reduces its expression levels and restrains the proliferation of esophageal squamous cell carcinoma (ESCC) cells, unveiling the oncogenesis role of TP63 in tumor malignancy [208]. The gene discussed is TP63; the disease is esophageal squamous cell carcinoma.